On December 18, 2023, the Department of Justice and the Federal Trade Commission issued the final version of their revised merger guidelines, which include modest changes from the agencie...
Last week, the FTC alleged that a private equity firm undertook a “multi-year anticompetitive scheme” to dominate Texas anesthesiology practices through: (1) “serial” acquisitions...
Last week, the FTC settled a director interlock lawsuit with EQT/Quantum, which is notable for three key reasons: (1) it confirms the FTC’s focus on enforcing the interlocking directora...
On July 19, 2023, the DOJ and FTC released a draft overhaul of the merger guidelines (the Draft Guidelines). Some portions of the Draft Guidelines are consistent with agency practice fro...
On July 10, 2023, Judge Jacqueline Scott Corley of the U.S. District Court for the Northern District of California denied the FTC’s motion for a preliminary injunction to block Microsof...
The U.S. antitrust authorities have proposed extensive changes to the Hart-Scott-Rodino filing requirements. If implemented, these changes will obligate filing parties to provide substant...
On February 3, the DOJ’s Antitrust Division withdrew three “outdated” policy statements. Those statements described certain antitrust safe harbors that companies in the healthcare ...
The Federal Trade Commission (FTC) has announced revised Hart-Scott-Rodino Act (HSR) reporting thresholds and filing fee amounts, up to a $2.25 million fee for the largest deals. Under th...
In a sweeping and controversial move, the FTC has proposed a rule that would bar almost all employment non-competes and require rescission of existing non-competes. The proposed rule is s...
In the U.S., some members of Congress and state AGs have advocated for greater antitrust scrutiny of industry-wide ESG initiatives, while other state AGs have argued that such initiatives...
